Jump to content

Dideoxyverticillin A: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
OAbot (talk | contribs)
m Open access bot: doi added to citation with #oabot.
 
(29 intermediate revisions by 22 users not shown)
Line 1: Line 1:
{{Chembox
{{Chembox
| ImageFile =
| ImageFile = 11,11'-Dideoxyverticillin A.svg
| ImageSize = 150px
| ImageSize = 250px
| ImageAlt =
| ImageAlt =
| PIN = (3''S'',3′''S'',5a''R'',5′a''R'',10b''R'',10′b''R'',11a''S'',11′a''S'')-2,2′,3,3′-Tetramethyl-2,2′,3,3′,5a,5′a,6,6′-octahydro-11''H'',11′''H''-[10b,10′b-bi-3,11a-disulfanopyrazino[1′,2′:1,5]pyrrolo[2,3-''b'']indole]-1,1′,4,4′-tetrone
| IUPACName =
| OtherNames = 11,11’-dideoxyverticillin A, 11,11’-dideoxyverticillin, CHEMBL2172426
| OtherNames = 11,11′-Dideoxyverticillin A; 11,11′-Dideoxyverticillin
| Section1 = {{Chembox Identifiers
|Section1={{Chembox Identifiers
| CASNo =
| CASNo = 12795-76-5
| CASNo_Ref = {{cascite|correct|CAS}}
| PubChem = 3084126
| UNII_Ref = {{fdacite|correct|FDA}}
| ChemSpiderID = 10477789
| SMILES = }}
| UNII = BDQ3M208XA
| PubChem = 3084126
| Section2 = {{Chembox Properties
| ChemSpiderID = 10477789
| Formula =
| MolarMass =
| ChEMBL = 2172426
| Appearance =
| SMILES = }}
|Section2={{Chembox Properties
| Density =
| C=30 | H=28 | N=6 | O=4 | S=4
| MeltingPt =
| BoilingPt =
| Appearance =
| Solubility = }}
| Density =
| MeltingPt =
| Section3 = {{Chembox Hazards
| MainHazards =
| BoilingPt =
| FlashPt =
| Solubility = }}
|Section3={{Chembox Hazards
| Autoignition = }}
| MainHazards =
| FlashPt =
| AutoignitionPt = }}
}}
}}


'''Dideoxyverticillin A''', also known as '''(+)-11,11′-dideoxyverticillin A''', is a complex epipolythiodioxopiperazine<ref>{{Cite journal | title = The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis |vauthors=Gardiner DM, Waring P, Howlett BJ | journal = Microbiology | date = April 2005 | volume = 151 | issue = 4 | pages = 1021–1032 | doi = 10.1099/mic.0.27847-0 | pmid = 15817772| doi-access = free }}</ref> initially isolated from the [[marine fungus]] ''[[Penicillium]]'' sp. in 1999.<ref>{{cite journal |vauthors=Son BW, Jensen PR, Kauffman CA, Fenical W | title = New cytotoxic epidithiodioxopiperazines related to verticillin A from a marine isolate of the fungus Penicillium | journal = Natural Product Letters | volume = 13 | issue = 3 | pages = 213–222 | date= May 1999 | doi = 10.1080/10575639908048788 }}</ref> It has also been found in the marine fungus ''[[Bionectriaceae]]'',<ref name="pmid22968289">{{cite journal |vauthors=Figueroa M, Graf TN, Ayers S, Adcock AF, Kroll DJ, Yang J, Swanson SM, Munoz-Acuna U, de Blanco EJ, Agrawal R, Wani MC | title = Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae | journal = The Journal of Antibiotics | volume = 65 | issue = 11 | pages = 559–564 | date= November 2012 | pmid = 22968289| doi = 10.1038/ja.2012.69 | pmc=3573876}}</ref> and belongs to a class of naturally occurring [[2,5-Diketopiperazine|2,5-diketopiperazines]].<ref name="pmid22575049">{{Cite journal | title = 2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products | author = Borthwick AD | journal = Chemical Reviews | date = May 2012 | volume = 112 | issue = 7 | pages = 3641–3716 | doi = 10.1021/cr200398y | pmid = 22575049}}</ref>
Dideoxyverticillin A (11,11’-dideoxyverticillin A) is a complex epipolythiodioxo-[[piperazine]] isolated from a marine fungus. Dideoxyverticillin A's reported anticancer mechanism is that it acts as a [[farnesyl transferase inhibitor]]. Dozens of semi-synthetic anticancer compounds have been made from Dideoxyverticillin A. [[Dimer (chemistry)|Dimeric]] derivatives are reported to have better anticancer activity.

Dideoxyverticillin A potently inhibits the [[tyrosine kinase]] activity of the [[epidermal growth factor receptor]] (median inhibitory concentration = 0.14 nM), exhibits antiangiogenic activity, and has efficacy against several cancer cell lines.<ref name="pmid22575049" /> Its reported anticancer mechanism is that it acts as a [[farnesyl transferase inhibitor]]. Dozens of semi-synthetic anticancer compounds have been made from dideoxyverticillin A. Dimeric derivatives are reported to have better anticancer activity.<ref name="pmid23914293">{{cite journal |vauthors=Boyer N, Morrison KC, Kim J, Hergenrother PJ, Movassaghi M | title = Synthesis and anticancer activity of epipolythiodiketopiperazine alkaloids | journal = Chemical Science | volume = 4 | issue = 4 | pages = 1646–1657 | date= 2013 | pmid = 23914293 | doi = 10.1039/C3SC50174D | pmc=3728915| url= http://dspace.mit.edu/bitstream/1721.1/95495/1/Movassaghi_Synthesis%20and.pdf }}</ref>

The [[enantioselective]] first total synthesis of (+)-11,11′-dideoxyverticillin A, the structure of which contains many sterically congested, [[wikt:contiguity|contiguous]] stereogenic centers as well as acid- and base-labile and [[redox]]-sensitive functionality, was biosynthetically inspired and achieved with high levels of chemical sophistication.<ref name="pmid19359584">{{cite journal |vauthors=Kim J, Ashenhurst JA, Movassaghi M | title = Total synthesis of (+)-11,11'-dideoxyverticillin A | journal = Science | volume = 324 | issue = 5924 | pages = 238–241 | date= April 2009 | pmid = 19359584 | doi = 10.1126/science.1170777 | pmc=4238916}}</ref>

==References==
{{Reflist}}


==External links==
==External links==
*[http://web.mit.edu/newsoffice/2013/chemists-find-help-from-nature-in-fighting-cancer-0227.html MIT News - 11,11’-Dideoxyverticillin]
*[http://web.mit.edu/newsoffice/2013/chemists-find-help-from-nature-in-fighting-cancer-0227.html MIT News - 11,11′-Dideoxyverticillin]
*{{cite journal |vauthors=Shi Y, Zhang Y, Ni Y, Shi G, Yang H |title=11-脱氧轮枝菌素A引起前列腺癌PC3M细胞Caspase依赖的凋亡 |trans-title=11'-Deoxyverticillin A induces caspase-dependent cell apoptosis in PC3M cells |language=zh |journal=Sheng Wu Gong Cheng Xue Bao |volume=28 |issue=1 |pages=96–103 |date=January 2012 |pmid=22667113 |url=http://d.wanfangdata.com.cn/Periodical_swgcxb201201011.aspx}}
*[http://www.ncbi.nlm.nih.gov/pubmed/22667113 11'-Deoxyverticillin A induces caspase-dependent cell apoptosis in PC3M cells]
*[http://www.ncbi.nlm.nih.gov/pubmed/22968289 Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae]


[[Category:Farnesyltransferase inhibitors]]
{{organic-chem-stub}}
[[Category:Bionectriaceae]]
[[Category:Diketopiperazines]]

Latest revision as of 01:14, 13 August 2023

Dideoxyverticillin A
Names
Preferred IUPAC name
(3S,3′S,5aR,5′aR,10bR,10′bR,11aS,11′aS)-2,2′,3,3′-Tetramethyl-2,2′,3,3′,5a,5′a,6,6′-octahydro-11H,11′H-[10b,10′b-bi-3,11a-disulfanopyrazino[1′,2′:1,5]pyrrolo[2,3-b]indole]-1,1′,4,4′-tetrone
Other names
11,11′-Dideoxyverticillin A; 11,11′-Dideoxyverticillin
Identifiers
ChEMBL
ChemSpider
UNII
Properties
C30H28N6O4S4
Molar mass 664.83 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Dideoxyverticillin A, also known as (+)-11,11′-dideoxyverticillin A, is a complex epipolythiodioxopiperazine[1] initially isolated from the marine fungus Penicillium sp. in 1999.[2] It has also been found in the marine fungus Bionectriaceae,[3] and belongs to a class of naturally occurring 2,5-diketopiperazines.[4]

Dideoxyverticillin A potently inhibits the tyrosine kinase activity of the epidermal growth factor receptor (median inhibitory concentration = 0.14 nM), exhibits antiangiogenic activity, and has efficacy against several cancer cell lines.[4] Its reported anticancer mechanism is that it acts as a farnesyl transferase inhibitor. Dozens of semi-synthetic anticancer compounds have been made from dideoxyverticillin A. Dimeric derivatives are reported to have better anticancer activity.[5]

The enantioselective first total synthesis of (+)-11,11′-dideoxyverticillin A, the structure of which contains many sterically congested, contiguous stereogenic centers as well as acid- and base-labile and redox-sensitive functionality, was biosynthetically inspired and achieved with high levels of chemical sophistication.[6]

References

[edit]
  1. ^ Gardiner DM, Waring P, Howlett BJ (April 2005). "The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis". Microbiology. 151 (4): 1021–1032. doi:10.1099/mic.0.27847-0. PMID 15817772.
  2. ^ Son BW, Jensen PR, Kauffman CA, Fenical W (May 1999). "New cytotoxic epidithiodioxopiperazines related to verticillin A from a marine isolate of the fungus Penicillium". Natural Product Letters. 13 (3): 213–222. doi:10.1080/10575639908048788.
  3. ^ Figueroa M, Graf TN, Ayers S, Adcock AF, Kroll DJ, Yang J, Swanson SM, Munoz-Acuna U, de Blanco EJ, Agrawal R, Wani MC (November 2012). "Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae". The Journal of Antibiotics. 65 (11): 559–564. doi:10.1038/ja.2012.69. PMC 3573876. PMID 22968289.
  4. ^ a b Borthwick AD (May 2012). "2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products". Chemical Reviews. 112 (7): 3641–3716. doi:10.1021/cr200398y. PMID 22575049.
  5. ^ Boyer N, Morrison KC, Kim J, Hergenrother PJ, Movassaghi M (2013). "Synthesis and anticancer activity of epipolythiodiketopiperazine alkaloids" (PDF). Chemical Science. 4 (4): 1646–1657. doi:10.1039/C3SC50174D. PMC 3728915. PMID 23914293.
  6. ^ Kim J, Ashenhurst JA, Movassaghi M (April 2009). "Total synthesis of (+)-11,11'-dideoxyverticillin A". Science. 324 (5924): 238–241. doi:10.1126/science.1170777. PMC 4238916. PMID 19359584.
[edit]